pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,694 catalysts · 3,350 8k filing · 2,088 grant · 1,110 approval · 1,000 device adverse event · 820 device 510k · 587 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: earnings×from 2026-01-12×clear all
type
  • 8k filing3,350
  • grant2,088
  • approval1,110
  • device adverse event1,000
  • device 510k820
  • device pma587
earnings
584
  • device recall307
  • recall215
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 12, 2026

    50
    ›Jan 12, 2026approval216d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 12, 2026approval216d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: ASCENT PHARMS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 12, 2026approval216d agoFLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (FLUTICASONE PROPIONATE) — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: RESPIRENT PHARMS. Form: POWDER. Route: INHALATION

    full page →fda approvals ↗
    ›Jan 12, 2026approval216d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 12, 2026approval216d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Jan 12, 2026approval216d agoZYCUBO (COPPER HISTIDINATE) — FDA approvalcopper histidinate

    Sponsor: SENTYNL THERAPS INC. Form: POWDER. Route: SUBCUTANEOUS

    full page →copper histidinate →fda approvals ↗
    ›Jan 13, 2026approval215d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 13, 2026approval215d agoYESAFILI (AFLIBERCEPT-JBVF) — FDA approvalYESAFILI

    Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

    full page →YESAFILI →fda approvals ↗
    ›Jan 13, 2026approval215d agoSODIUM BICARBONATE — FDA approvalSODIUM BICARBONATE

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAVENOUS

    full page →SODIUM BICARBONATE →fda approvals ↗
    ›Jan 13, 2026approval215d agoISOVUE-250 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 13, 2026approval215d agoISOVUE-370 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 13, 2026approval215d agoBENAZEPRIL HYDROCHLORIDE — FDA approvalBENAZEPRIL HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →BENAZEPRIL HYDROCHLORIDE →fda approvals ↗
    ›Jan 13, 2026approval215d agoDEFLAZACORT — FDA approvalDEFLAZACORT

    Sponsor: ZYDUS LIFESCIENCES. Form: SUSPENSION. Route: ORAL

    full page →DEFLAZACORT →fda approvals ↗
    ›Jan 14, 2026approval214d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoMEN'S ROGAINE (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval214d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Jan 14, 2026approval214d agoROGAINE (FOR WOMEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval214d agoFLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (FLUCONAZOLE) — FDA approvalDiflucan

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Diflucan →fda approvals ↗
    ›Jan 14, 2026approval214d agoAVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalAVTOZMA

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →AVTOZMA →fda approvals ↗
    ›Jan 14, 2026approval214d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Jan 14, 2026approval214d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: LAURUS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoGLEEVEC (IMATINIB MESYLATE) — FDA approvalImatinib Mesylate Shilpa

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →Imatinib Mesylate Shilpa →fda approvals ↗
    ›Jan 14, 2026approval214d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: LAURUS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: SOMERSET THERAPS LLC. Form: TABLET

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval214d agoELTROMBOPAG OLAMINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

    Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoTOREMIFENE CITRATE — FDA approvalTOREMIFENE CITRATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →TOREMIFENE CITRATE →fda approvals ↗
    ›Jan 14, 2026approval214d agoMYCOPHENOLATE SODIUM — FDA approvalmycophenolate sodium DR

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →mycophenolate sodium DR →fda approvals ↗
    ›Jan 14, 2026approval214d agoROGAINE EXTRA STRENGTH (FOR MEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoSITAGLIPTIN PHOSPHATE — FDA approvalSITAGLIPTIN PHOSPHATE

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →SITAGLIPTIN PHOSPHATE →fda approvals ↗
    ›Jan 14, 2026approval214d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Jan 14, 2026approval214d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

    Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

    Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 14, 2026approval214d agoANAGRELIDE HYDROCHLORIDE — FDA approvalANAGRELIDE HYDROCHLORIDE

    Sponsor: RISING. Form: CAPSULE. Route: ORAL

    full page →ANAGRELIDE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval213d agoOSELTAMIVIR PHOSPHATE — FDA approvalOSELTAMIVIR PHOSPHATE

    Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →OSELTAMIVIR PHOSPHATE →fda approvals ↗
    ›Jan 15, 2026approval213d agoREZUROCK (BELUMOSUDIL MESYLATE) — FDA approvalbelumosudil mesylate

    Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL

    full page →belumosudil mesylate →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval213d agoOTULFI (USTEKINUMAB-AAUZ) — FDA approvalOTULFI

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →OTULFI →fda approvals ↗
    ›Jan 15, 2026approval213d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Jan 15, 2026approval213d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ← prev
    page 1 of 34
    next →
    $IGC0.2670+0.41%
    $MANE112.71+1.54%
    $PFE26.79-0.04%
    $MANE112.71+1.54%
    $PFE26.79-0.04%
    $HCWB
    $AMRX18.15+5.10%
    $NVS150.88-0.55%
    $MANE112.71+1.54%
    $AMRX18.15+5.10%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%
    $COLL28.23+0.28%